Lograns Pharma Private Limited
About Lograns Pharma Private Limited
Data last updated:
Lograns Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 December 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2006PTC052130. Its GSTIN is 36AABCL2581M1Z8 (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Asa Jyothi Bommareddy and Venkateswara Reddy Bommareddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹45.53 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹16,559 (net margin 0.4%) and EBITDA of ₹1.28 Lakh (EBITDA margin 2.8%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No: 68 First Floor. Road No: 7 Aleap Industrial Estate Quthbullapur (M, Andal), Hyderabad, Telangana, India – 500090
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Lograns Pharma Private Limited
The main business activity of Lograns Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Lograns Pharma Private Limited FY 2025 filings available
Lograns Pharma Private Limited reported revenue of ₹45.53 Lakh (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Lograns Pharma Private Limited
Revenue rose 14% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Lograns Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.28 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹16,559 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Lograns Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lograns Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Lograns Pharma Private Limited
Lograns Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gloled Pharma Pvt Ltd | ₹46.06 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Haryana, India |
| Fantasy Pharma Ventures Private Limited | ₹45.9 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | Bangalore, Karnataka, India |
| Avtos Life Sciences Private Limited | ₹45.81 Lakh (FY 2025) | •••• | •••• | -86.0% | •••• | Navi Mumbai, Maharashtra, India |
| Curemart Pharma Private Limited | ₹45.79 Lakh (FY 2024) | •••• | •••• | 2066.0% | •••• | New Delhi, Delhi, India |
| Ctga Biopharma India Private Limited | ₹45.77 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Hyderabad, Telangana, India |
| Lograns Pharma Private Limited this company | ₹45.53 Lakh (FY 2025) | •••• | •••• | 14.0% | •••• | Hyderabad, Telangana, India |
| D-Cure Pharmaceuticals Private Limited | ₹45.43 Lakh (FY 2024) | •••• | •••• | 16.0% | •••• | Delhi, India |
| Arcetic Life Sciences Private Limited | ₹45.39 Lakh (FY 2025) | •••• | •••• | 4185.0% | •••• | Pune, Maharashtra, India |
| Lepidus Pharma India Private Limited | ₹45.31 Lakh (FY 2016) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Jeevadravya Bio-Pharma Private Limited | ₹45.18 Lakh (FY 2025) | •••• | •••• | 3244.0% | •••• | Pune, Maharashtra, India |
| Cardea Venture Private Limited | ₹45.12 Lakh (FY 2025) | •••• | •••• | 5129.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Lograns Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Lograns Pharma Private Limited
Lograns Pharma Private Limited is audited by JYOTHI BAS K&CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JYOTHI BAS K&CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Lograns Pharma Private Limited
Lograns Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Asa Jyothi Bommareddy | Director | 30 Oct 2019 | 6 Years 11 Months | Current |
| Venkateswara Reddy Bommareddy | Director | 27 Dec 2006 | 19 Years 9 Months | Current |
Ownership and Shareholding of Lograns Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Lograns Pharma Private Limited
Lograns Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Lograns Pharma Private Limited
Employment history and EPFO contributions of people linked to Lograns Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Lograns Pharma Private Limited
Lograns Pharma has one previous CIN (Corporate Identification Number): U24232AP2006PTC052130. The current CIN is U24232TG2006PTC052130, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2006PTC052130 | Current |
| U24232AP2006PTC052130 | Previous |
Recent Activity on Lograns Pharma Private Limited
Lograns Pharma Private Limited has 5 board changes on record since 2006: 2 appointments and 3 cessations. The latest: Asa Jyothi Bommareddy ceased to be Additional Director on 31 Dec 2020.
Credit Ratings, Litigation & Regulatory Alerts for Lograns Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lograns Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lograns Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lograns Pharma Private Limited
Lograns Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCL2581M1Z8 | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lograns Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lograns Pharma Private Limited
Lograns Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 December 2006 (20+ years old) and is registered under CIN U24232TG2006PTC052130.
Lograns Pharma reported revenue of ₹45.53 Lakh for FY 2025 (up 14% YoY).
Lograns Pharma has 2 current directors:
- Asa Jyothi Bommareddy - Director
- Venkateswara Reddy Bommareddy - Director
Lograns Pharma reported a net profit of ₹16,559 (net margin 0.4%) and EBITDA of ₹1.28 Lakh (EBITDA margin 2.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Lograns Pharma is 8% over three years and -4% over five years. In the latest year (FY 2025) revenue rose 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Lograns Pharma is 36AABCL2581M1Z8, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Lograns Pharma is U24232TG2006PTC052130. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lograns Pharma was incorporated on 27 December 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Lograns Pharma by revenue are Gloled Pharma Pvt Ltd, Fantasy Pharma Ventures Private Limited, Avtos Life Sciences Private Limited, Curemart Pharma Private Limited, Ctga Biopharma India Private Limited and 5 more, all in the Pharma industry (Formulations).
Asa Jyothi Bommareddy ceased to be Additional Director on 31 Dec 2020. Asa Jyothi Bommareddy was appointed as Director on 30 Oct 2019. Bomma Reddy Chowdari Reddy ceased to be Director on 20 Jul 2019. Lograns Pharma has 5 board changes on record in total.
The registered office of Lograns Pharma is at Plot No: 68 First Floor. Road No: 7 Aleap Industrial Estate Quthbullapur M, Andal, Hyderabad, Telangana, India – 500090.